Global Norms, Standards and Test Methods in UV Protection
Global Norms & Standards / SPF
SPF Range
Proposed Monograph SPF 50+ Max.
Claims
In-vivo SPF = Claimed SPF
Relevant Test Method
In-vivo SPF FDA Method
2
Max. SPF 50+
Max. SPF 30+
In-vivo SPF In-vivo SPF = Claimed = Claimed SPF SPF
Max. SPF 50+
Max. SPF 50+
Categories: low, medium, high & very high protection SPF claim specified: 6, 10, 15, 20, 25, 30, 50 and 50+
In-vivo SPF ISO24444 Method
Max. SPF 99
Categories like EU but individual SPF claim possible Colipa and ISO method
Erythemal Effectiveness of Sunlight
EA( ), SI( ) / arbitrary units
UVB
UVA
308nm
1
Erythemal Action Spectrum Standard Sun Spectrum Erythemal Effectiveness 0 290
310
330
350
/ nm 3
Technical Service SunCare E-EMV/GU
370
390
SPF measurement in vivo SPF represents mainly a protection in the UVB range UVAII contributes to 20 % to SPF
E I SPF E I T 400
290 400 290
Biological response = sunburn = max at 308nm (UVB)
T = Sunscreen Transmittance at E = Spectral irradiance of UV source at I = Erythemal action spectrum at Technical Service SunCare E-EMV/GU
4
SPF measurement in vivo Principle: Measurement of the UV induced erythema 20 ± 4h after irradiation Conditions: Xenon lamp solar simulator with Cosmetic Europe Standard UV spectrum
Application: 2 mg/cm² Choice of an adequate panel of human volunteers 10 to 20 subjects max., skin types I, II and III
(screening only on 5 volunteers)
5
Technical Service SunCare E-EMV/GU
Impact of Application Amount on SPF
60
SPF (calc.)
50 40 30 20 10 0
In-vivo SPF measurement
=35g / Application =
2mg/cm2
Reality
1.5mg/cm2
1mg/cm2
0.5mg/cm2
Linear correlation between SPF and film thickness 6
Technical Service SunCare E-EMV/DU
SPF measurement in vivo Principle: Measurement of the UV induced erythema 20 ± 4h after irradiation Conditions: Xenon lamp solar simulator with COLIPA Standard UV spectrum
Application: 2 mg/cm² Choice of an adequate panel of human volunteers 10 to 20 subjects max., skin types I, II and III
(screening only on 5 volunteers)
7
Technical Service SunCare E-EMV/DU
The different skin types
Self Protection Time / Minutes
80 70
>70
60 50 40 30
Skin types for in-vivo SPF testing
20 10
<10
10-15
15-30
30-60
20-45
0
Type 1
8
Type 2
Type 3
Type 4
Type 5
Type 6
data based on the conditions of a clear day in early July at noon time, 32° latitude North (T.B. Fitzpatrick, Archives of Dermatology, 124, 1988, p.869)
BASF Personal Care
SPF measurement in vivo Determination: UV exposure in defined MED steps
Pretest: Determination of Minimal Erythemal Dose = MED
MED: quantity of UV radiation required to produce the first perceptible, unambiguous redness reaction with clearly defined borders
SPF = MED p / MED up P = Protected aera
Up = Unprotected aera
9
Technical Service SunCare E-EMV/DU
SPF 50 protects five times better than SPF10
10
http://www.youtube.com/watch?v=8cc8qRr7oMQ
SPF measurement in vivo Limitations: Reproducibility from institute to institute Reproducibility from day to day SPF (US) not the same as SPF (EU) not the same as SPF (Asia) Ethics Price Does not represent protection over the whole UV (Sunburn protection = UVB mainly) Application rate (2 mg/cm²) not used by consumers 0.5-1 mg/cm² is the amount used => less protection as indicated !
11
Technical Service SunCare E-EMV/GU
SPF measurement in vitro Principle:
In vitro SPF calculated from the spectral transmittance of UV light from 290 to 400nm Measurement through a sunscreen film on a rough surface (PMMA plates).
Technical Service SunCare E-EMV/GU
12
SPF measurement in vitro Equipment: Labsphere UV Transmittance analyzer UV-2000S
Technical Service SunCare E-EMV/GU
13
SPF measurement in vitro BASF Conditions: Application: 1.2 mg/cm² on sandblasted PMMA plates (Helioscience) 4 plates with 11 measurements on each plate Blank with glycerin
Technical Service SunCare E-EMV/GU
15
SPF measurement in vitro Limitations: Different methods – no harmonized method
Equipment and application techniques not harmonized Strong influence of individual application technique Photostability is not taken into account by most of the methods Influence of product rheology Conclusion: In vitro SPF suitable for comparison and evaluation of similar formulations. Determination of absolute SPF level difficult
Technical Service SunCare E-EMV/GU
16
Global Norms & Standards / UVA-PF UVA protection
Claims
Test Method
Max. UVA needed 17
Critical Wavelength
UVA-PF
UVA-PF
UVA-PF
CW >370 = Broad spectrum SPF>15 → decreases risk of skin cancer
PA+ PA++ PA+++
PA+ PA++ PA+++ PA++++ (01.2013)
UVA-PF/SPF ≥ 1/3 / CW >370
CW / FDA final rule 2011
PPD invivo ISO 24442
PPD invivo ISO 24442
>8
>8
>16
UVA/ UVB ratio
UVA-PF
UVA-PF/SPF ≥ 1/3 / CW >370 ULTRA
UVA-PF invitro ISO24443 (PPD ISO 24442 EU only)
>20
UVA/UVB ratio (incl. Photostability)
>30
UVA-PF invitro ISO24443 or PPD ISO 24442
>33
UVA Test Methods In vivo method UVA – PF (PPD) In vivo / in vitro method UVA-PF ”in vitro” / SPF label (EC recommendation – Cosmetic Europe Method)
In vitro methods UVA/UVB ratio
Technical Service SunCare E-EMV/GU
18
In vivo: UVA-PF (PPD) acc. to JCIA Measurement Persistent Pigment Darkening = PPD
E I UVA PF E I T 400
320 400
320
= Biological Action Spectrum Where : T = Sunscreen Transmittance at E = Spectral irradiatance of UV source at I = Biological action spectrum at
= Persitent Pigment Darkening
Technical Service SunCare E-EMV/GU
19
In vivo: UVA-PF (PPD) Conditions: Xenon lamp, spectrum: 320 to 400 nm 10 volunteers of skin types II, III and IV
The Minimal Pigmenting Dose (MPD) corresponds to the minimal UVA dose producing a minimal darkening effect 2 hours after exposure to 6 increasing doses of UVA.
UVA PF = MDPp / MPD up The MPD for the protected area (MPDp) is then compared with the MPD for the unprotected area (MPDup). 20
Technical Service SunCare E-EMV/GU
The different skin types
Self Protection Time / Minutes
80 70
>70
60 50
Test subjects for in-vivo UVA-PF
40 30
30-60
20 10 0
<10
Type 1
10-15
Type 2
15-30
Type 3
20-45
Type 4
Type 5
Type 6
data based on the conditions of a clear day in early July at noon time, 32° latitude North (T.B. Fitzpatrick, Archives of Dermatology, 124, 1988, p.869) 21
Technical Service SunCare E-EMV/GU
In vivo: UVA-PF (PPD) PPD is the standard method in Japan for UVA assessment Japan Cosmetic Industry Association adopted a classification scheme rather than numerical values for expressing UVA protection
UVA-PF
<2
No protection Classification against UVA Claims
4-8
8 – 16
>16*
PA +
PA ++
PA +++
PA ++++
Protection Considerable High Greatest No claims against Protection protection protection UVA
* From 13 January 2013 22
2-4
Technical Service SunCare E-EMV/GU
In vivo: UVA-PF (PPD) Benefit:
Takes photostability into account PPD is the skin‘s response to UVA (connected to skin damage via free radicals)
Limitation:
Difficulty to standardize
23
Technical Service SunCare E-EMV/GU
In-vitro UVA-PF (Cosmetic EU Guideline 2011) Principle:
In vitro transmission measurement ( measurement in vitro SPF (solar spectrum – erythema action spectrum) Mathematical adjustment of the transmission spectrum such that the in vitro SPF equals the labeled in vivo SPF, by applying a constant c as exponent for the transmissions 1,2
Absorbance
1 0,8 0,6
14 13 12
0,4
In-vitro measured absorption spectrum
0,2
11
Calculated SPF
Adapted Spectrum would reach claimed SPF
10
0
290
300
310
320
330
340
350 360 370 380 390 400 Technical Service SunCare E-EMV/GU
24
In-vitro UVA-PF (Cosmetic EU Guideline 2011) Calculation of the UVA-PF in vitro between 320 and 400 nm using the adjusted transmission curve (together with the PPD action spectrum and the spectrum of the UVA lamp) Irradiation linked to UVA-PF static D = 1,2 J/cm² X UVA-PF static In vitro transmission measurement after irradiation calculation of the UVA-PF in vitro after irradiation using the same coefficient c Calculation of the Colipa ratio :
SPF label / UVA-PF in vitro a.i.
< 3
Technical Service SunCare E-EMV/GU
25
In-vitro UVA-PF (Cosmetic EU Guideline 2011)
Conditions:
Blank: Glycerin
Application: –
1.3 mg/cm² on moulded HD6 plates (2011 revision)
3 plates with 4 measurements on each plate
Irradiation dose is UVA-PF dependent (UVA-PF X 1.2J/cm²)
Critical wavelength is measured after irradiation
If Lc >370nm AND
Cosmetic EU ratio method 2011
UVA-PF / SPF ≥ 1/3
Technical Service SunCare E-EMV/GU
26
In-vitro UVA-PF - EC recommendation Benefits Expression of the UVA protection in relation to the SPF
Photostability is taken into account
27
Technical Service SunCare E-EMV/GU
In vitro: BOOTS STAR RATING UVA/UVB-ratio (2011 revision)
Conditions:
In vitro transmission measurement
Blank with Glycerin Quartz or PMMA plates (2 – 4µm) Application amount: 1 mg/cm² Irradiation dose: 17,5 J/cm² (3MED)
Technical Service SunCare E-EMV/GU
28
In vitro: BOOTS STAR RATING UVA/UVB-ratio (2011 revision)
Ratio of the average absorption in the UVA- (320-400 nm) to that in the UVB-(290-320 nm) range of the absorption spectrum of a product Before and after 17.5J/cm² 700 600
E (1%,1cm)
500 400 300 200
UV-A
UV-B
100 0 290
310
330
350
370
390
Wavelength / nm Technical Service SunCare E-EMV/GU
29
In vitro: BOOTS STAR RATING UVA/UVB-ratio (2011 revision)
Allocation of star ratings from to stars
UVA/UVB RATIO after irradiation
0.0 - 0.56 0.57 - 0.75 0.76 - 0.85 0.86 -…
0.0 to 0.59 No Rating No Rating No Rating No Rating
INITIAL UVA/UVB RATIO 0.6 to 0.79 0.8 to 0.89 No Rating No Rating
0.9 and over No Rating
ratio of zero :
No UVA absorbance
ratio of < 0,5
UVB absorber
ratio of 1,0 :
Equal UVA and UVB absorbance (broad spectrum filter system)
ratio of > 1,0
UVA absorber Technical Service SunCare E-EMV/GU
30
Overview Sun Care Portfolio 2013 Global Technical Service Sun Care E-EMC/DU
UV Filter Performance Overview
35
Why a new UV filter? 320 - 340nm
1600
UVB
UVAII
UVAI
E (1,1)
1200
800
400
0 290 295 300 305 310 315 320 325 330 335 340 345 350 355 360 365 370 375 380 385 390 395 400
Wavelenght [nm] UVB absorber
UVA absorber
Current lack of performance in UVA II 36
E-EMC/DU Technical Service SunCare
Why a new UV filter? 320 - 340nm
1600
UVB
UVAII
UVAI
E (1,1)
1200
800
400
0 290 295 300 305 310 315 320 325 330 335 340 345 350 355 360 365 370 375 380 385 390 395 400 Wavelenght [nm] UVB absorber
Tinosorb A2B (Active)
UVA absorber
High performance of Tinosorb® A2B in UVA II 37
E-EMC/DU Technical Service SunCare
Tinosorb® A2B - Product data Form
Aqueous dispersion ~50% active ingredient
Structure
N
N N
INCI
Tris-Biphenyl Triazine (nano) (Abbr: TBPT)
Emax. (1,1)
1100
max
315 nm
Concentration maximum
20% (=10% TBPT)
Molecular mass
537.22 g/mol
Melting Point
261°C
38
E-EMC/DU Technical Service SunCare
Tinosorb®A2B - Particle Size and Efficacy Absorbance spectrum dependent on the particle size Optimal performance achieved with a particle size of around 100nm Same effect observed for organic as well as inorganic particulate UV filters
40
Tinosorb® A2B – Boosting effect with soluble UV filters Performance by: Absorption, Reflection & Scattering
UV Light Other non particulate filters
Tinosorb® A2B
Skin 42
Tinosorb® A2B - Total UV Absorbance Comparison to other UVB Filters 600
Area = Total absorbance Area- 400 nm from 290
500
400
300
200
100
0 HMS
EHS
BMP
OCR (Uvinul N539T)
TiO2
B3
PBSA
EHMC (Uvinul MC 80)
IMC
DBT
EHT TBPT (Uvinul T (Tinosorb 150) A2B-active)
Tinosorb® A2B (TBPT) most efficient contributor to SPF 44
INTERN - Tinosorb®A2B Challenge Session
Tinosorb® A2B - Contribution to SPF Comparison to EHMC, EHT and PBSA 14 12
SPF
10
TBPT in vivo
8
TBPT 6
EHMC 4
PBSA EHT
2 0
0
2
4
In silico data calculated on BASF Sunscreen Simulator (www.basf.com/sunscreen-simulator)
6
8
10
12
Concentration %
By incorporating Tinosorb® A2B higher SPF with lower UV filter concentration more formulation flexibility 45
Tinosorb® A2B - Photostability Comparison to other UVB Filters
Determined by HPLC method
Tinosorb® A2B is photostable 46
INTERN - E-EMV/GU - BASF confidential
Tinosorb® A2B Incorporation Instructions Emulsifiers
Recommended incorporation process Generally, possible with all incorporation methods
O/W
Recommended incorporation:
Non ionic
After emulsification (predilution into water), below 50°C, under stirring – final high shear homogenization possible
Anionic
Cationic
Possible with all incorporation methods with tested emulsifiers – final high shear homogenization possible
Incompatibility with cationic emulsifiers whatever the incorporation process is Cationics with low charge might work
W/O emulsifiers 47
After emulsification (with predilution into water), below 50°C, under stirring – final high shear homogenization possible
E-EMC/DU Technical Service SunCare
Tinosorb® A2B Performance in a Sunscreen Formulation 2,5
320 - 340nm
SPF 30
Absorbance
2
1,5
SPF 20 1
Base Base + 4% Tinosorb®A2B
0,5
0 290
310
330
350
370
390
Wavelength (nm)
High contribution of Tinosorb® A2B to UVB & UVA II performance 48
INTERN - E-EMV/GU - BASF confidential
Tinosorb® A2B – performance in a photostable UVA base – SPF 30 UVA-PF in vitro / Addition of UVB filter
SPF in vivo SPF claimed 30
Base (UV09071-1-1)
17.2
>1/3
+ 3% PBSA (UV09071-1-4)
28.8
< 1/3
25.1
< 1/3
+ 3% TiO2 active ingr. (UV09071-1-6)
+ 3% EHMC (UV09071-1-3)
Base: 3% Uvinul®T150 1% Tinosorb®S
28.2
< 1/3
4% Uvinul®A Plus + 3% DBT (UV12103-1-1)
37.2
< 1/3
43.0
> 1/3
+ 6% Tinosorb®A2B (3% active) (UV12103-1-4)
By incorporating Tinosorb®A2B significant increase of SPF without unbalancing the absorbance in the UVA The filter combination above is for research purpose only. The combination of Uvinul® A Plus and Tinosorb® A2B is blocked by the patent rights of EP2196189 and the equivalent patent rights thereof in many countries.
49
E-EMC/DU Technical Service SunCare
Tinosorb® A2B – performance in a photostabilized UVA base – SPF 30 Addition of UVB filter
UVA-PF in vitro / SPF in vivo SPF claimed 30
Base
20.3 +/- 4.4
>1/3
+ 3% EHMC
28.7 +/- 3.5
< 1/3
+ 3% PBSA
33.4 +/- 3.8
< 1/3
+ 3% EHT
39.4 +/- 5.7
< 1/3
+ 3% DBT
27,0 +/- 6.1
<1/3
+ 3% TiO2
28.3 +/- 7.5
> 1/3 10.1
+ 6% Tinosorb® A2B (3% active)
36.9 +/- 3.7
> 1/3 13.5
Base: 6.0% OCR 2.0% BMDBM 1.0% Tinosorb® S
4.5% Tinosorb® M
By incorporating Tinosorb® A2B significant increase of SPF without unbalancing the absorbance in the UVA fills the gap 50
E-EMC/DU Technical Service SunCare
in-cosmetics 2013
Photostable UVA Protection 15
20
30
50
UV12063-1-3
UV12063-2-2
UV12063-3-3
UV12063-4-6
Uvinul®MC80
5.0
5.0
7.5
7.5
Tinosorb®A2B
1.5
3.0
4.0
8.0
UVA
Uvinul®A Plus
2.0
3.0
5.0
5.0
B-S
Tinosorb®M
---
---
---
5.0
Colipa
5.1 > 1/3
7.1 > 1/3
10.4 > 1/3
16.8 > 1/3
PA claim cal.
PA++
PA++
P+++
PA ++++
SPF cal.
16.3
21.6
32.7
52.4
Claimed SPF UVB
UVA-PF in vitro a.i.
a.i.- after irradiation The filter combination above is for research purpose only. The combination of Uvinul® A Plus and Tinosorb® A2B is blocked by the patent rights of EP2196189 and the equivalent patent rights thereof in many countries. 51
E-EMC/DU Technical Service SunCare
Light Feeling Sun Care Cream SPF 50 GEUV12063-4-6
The filter combination above is for research purpose only. The combination of Uvinul® A Plus and Tinosorb® A2B is blocked by the patent rights of EP2196189 and the equivalent patent rights thereof in many countries.
52
E-EMC/DU Technical Service SunCare
Highest Performance •
For high SPFs with high UVA protection high amount of crystalline UV filters are required
•
Solubility limitations of crystalline UV filters require high amounts of emollients
•
High emollient loads leads to heavy formulations and are difficult to stabilize
Particulate UV filters for the water phase can help to reduce the load of emollients
53
E-EMC/DU Technical Service SunCare
High Performance Sun Screens with „Dry Touch“ Appearance 50
50
50
10.0%
10.0%
10.0%
---
4.0%
4.0%
DBT
4.5%
---
---
UVA
BMDBM
5.0%
3.0%
3.0%
B-S
Tinosorb® S
3.5%
2.0%
1.0%
---
---
1.0%
Total Filter concentration
23%
19%
19%
UVA-PF calc.
17.1
18.9
19.6
UVA-PF / SPF
>1/3
>1/3
>1/3
SPF calc.
49.7
52.0
50.8
Required Cetiol® AB Equivalents
23%
10%
7%
Claimed SPF UVB
Uvinul® N539T (OCR) Tinosorb® A2B (active)
Tinosorb® M (active)
Identical performance, reduced oil phase by the use of particulated UV filters 54
Tinosorb® A2B - Summary Benefits of Tinosorb® A2B Unique absorbance spectrum By addition of Tinosorb® A2B, the SPF is increased and the absorbance spectrum is kept balanced to still meet the required UVA protection Its introduction to the water phase offers more flexibility for the formulator Thanks to its particulate form, Tinosorb® A2B offers a boosting effect of other dissolved UV filters Compatible with all commonly used UV filters
Compatible with commonly used cosmetic raw materials including Ethanol Fill the GAP with Tinosorb® A2B 55
E-EMC/DU Technical Service SunCare
Tinosorb® M Profile INCI name:
Methylene Bis-Benzotriazolyl Tetramethylbutylphenol (nano) (MBBT)
US FDA Drug name:
Bisoctrizole
Appearance:
Dispersion of microfine, organic particles
CAS Number:
103597-45-1
Dispersion:
Tinosorb® M 46.0 - 55.0 % 6.0 - 10.0 % 0.2 - 0.6 % 0.1 - 0.5 % ad 100 % pH value 11
UV Spectrum Tinosorb M
MBBT particles Decyl Glucoside Propylene Glycol Xanthan Gum Water
Melting point:
195 ℃
Type:
Water dispersion
Molecular mass:
658.86 g/mol
Solubility in H2O:
< 10-8 g/l
Approved use conc.: 20% Tinosorb® M (10 % active) EU, JP, Asia US pending 56
Size of Common of UV Filters UV Filter Categories
Molecular Weight
PBSA, EHMC
< 300 Da
< 1 nm
EHT, BEMT
> 500 Da
> 1 nm
6000Da
3 nm
>3’000’000 Da
20-500 nm
Polisilicone-15 (Polymer)
MBBT, TBPT Microfine organic particles, partially “Nano”
Size Molecule / Particle Diameter
(= smallest particles)
Which UV Filters will penetrate into the skin most? For UV Filters Nano is BIG ! 57
BASF Personal Care
20 nm
®M ® T Tinosorb Uvinul
150
Benefits Tinosorb® M, a broad-spectrum UV filter available for the water phase Microfine organic particles in water increases flexibility regarding the oil phase
Synergy effect with oil soluble UV filters Absolutely photostable The only UV-filter with significant absorbance close to visible light High contribution to UVA-PF due to strong absorbance in long UVAI The only completely white UVA filter Positive impact formulation color
58
Tinosorb® M Triple Action
Tinosorb M provides absorption, reflection and scattering = Triple Action 59
Tinosorb® M
SPF in vivo (International Method)
Combined with EHMC - Synergy Effect
8% Tinosorb® M
Benefit:
5% EHMC
5% EHMC + 8% Tinosorb® M
Synergistic effect with EHMC improves the SPF
5% EHMC + 16% Tinosorb® M
Tinosorb® M Combination with oil soluble UV filters Tinosorb® M: dispersion of the filter in the water phase (O/W)
Oil droplets (black) protection by oil soluble UV filter
By combination of Tinosorb® M and oil soluble UV filter protection in both emulsion phases = boosting effect 07.03.2012
62
Tinosorb® M Stabilization of EHMC
EHMC 2.4%
- 27%
3.4% EHMC & 10% Tinosorb® M
- 8%
Tinosorb® M provides efficient stabilization of EHMC 07.03.2012
63
Tinosorb® M Impact of Filter Composition on Formulation Color
Filter composition
UVA-PF (Colipa)
Gel cream
Gel cream
(UV09100-1-3)
(UV09100-1-4)
7% Uvinul® MC80 5% Uvinul® A Plus 1% Tinosorb® S
5% Uvinul® MC80 2% Uvinul® A Plus 1% Tinosorb® S 4% Tinosorb® M
21.5
21.3
Impact on emulsion color
Identical UVA performance, difference in formulation colour 07.03.2012
65
Tinosorb® M Modification of Skin Sensory Reduction of skin stickiness
Stickiness
more
less
71
Tinosorb® M Formulation Tips Add Tinosorb® M to the final formulation at low temperature at efficient stirring (or even homogenization)
Combine Tinosorb® M with oil soluble UV filters in order to achieve synergy effect
Compensate potential stickiness by the use of light emollients or sensory enhancers
Check stability carefully in case cationic emulsifiers are used
77
Tinosorb® S Profile INCI-Name:
Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine (BEMT)
US FDA Drug Name (USP): Bemotrizinol Appearance:
Slightly yellow powder
CAS Number:
187393 – 00 – 6
Melting point:
80°C
Type:
Oil soluble
Molecular mass:
627.8 g/mol
Solubility in H2O:
10-7 g/l
Approved use conc.:
10% (EU), 10% (Asia), 3% (JP) US pending
UV Spectrum Tinosorb S
78
®S ® Tinosorb Uvinul
T 150
Benefits Tinosorb® S, the only and most efficient oil soluble broadspectrum UV filter High contribution to SPF High UVA-PF already at low concentration Best fit with all approaches in Sun Care Outstanding photostability Efficient stabilizer for photoinstable UV filters
79
Tinosorb® S Inherent Photostability by Photo-Tautomerism R1
R4
O N H
N
R2
N R5
R3
h R1
tc
=10-12
sec
R4
N
N
O H
R2
N 07.03.2012
R5
R3
80
Tinosorb® S Contribution to UVA-PF
UVA-PF (PPD method)
Formulation Base 10 9 8 7 6 5 4 3 2 1 0
Addition of Tinosorb S
7% EHMC 1.5% ZnO 3.0% TiO2
Base
+ 1%
+ 2% % Tinosorb® S
+ 3%
Tinosorb® S provides good UVA-PF at low concentration 81
Tinosorb® S Contribution to SPF
SPF in-vivo
(International Method)
34 32
Addition of Tinosorb S
Formulation Base 7.0% EHMC 1.5% ZnO 3.0% TiO2
30 28 26 24 22 20 18 Base
+ 1%
+ 2%
%
Tinosorb®
+ 3%
S
Tinosorb®S provides good SPF at low concentration 82
Tinosorb® S Stabilization of EHMC
3.4% EHMC & 2% Tinosorb® S
- 42%
EHMC 3.4%
- 19%
Tinosorb® S provides efficient stabilization of EHMC 84
Tinosorb® S Solubility in selected Cosmetic Oils
Cosmetic Oils
86
Tinosorb® S Microscopic Evaluation of Crystals
Magnification, x 125
BEMT: Needle form crystals 88
Tinosorb® S Formulation Tips Choose polar emollients with best solubility for Tinosorb® S such as e.g. Ethylhexyl Methoxycinnamate (Uvinul® MC80), Ethylhexyl Salicylate (Neoheliopan Type OS), Dicaprylyl Carbonate (Cetiol® CC), C12-15 Alkyl Benzoate (Cetiol® AB), Dibutyl Adipate (Cetiol® B)
The oil phase might be adapted in order to solubilize Tinosorb® S and other oil soluble filters completely.
Dissolve Tinosorb® S completely in the oil phase
Check potential crystallization (microscopy) at low storage temperatures
94
Limitations in Sun Care Formulations Formulations with high SPF need high load of filter concentration Most filters are either oils or need to be dissolved in polar emollients The oil phase has to be adapted depending on the oil soluble filters in quantity as well as in quality High oil phases reduce the flexibility to modify sensory of formulations Use of filter mainly in one formulation phase often achieve lower performance than expected
Tinosorb® S Aqua = more formulation flexibility 96
Tinosorb® S Aqua Profile INCI-Name:
Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine (and) Polymethyl Methacrylate
US FDA Drug Name (USP): Bemotrizinol UV Spectrum Appearance:
Slight yellow liquid dispersion
CAS Number:
187393–00–6/ 9011–14-7/ 1335-72-4/ 124-68-5
Dispersion:
Tinosorb® S Aqua 18.0 - 22.0 % 17.0 - 21.0 % 1.0 - 2.0 % 0.4 - 0.8 % ad 100 pH value 8-11
Tinosorb® S Aqua
Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine Polymethylmethacrylate Sodium Laureth Sulfate Amino Methyl Propanol
Type:
Water dispersion
Molecular mass:
627.8 g/mol
Solubility in H2O:
10-7 g/l
Approved use conc.:
50% EU, Asia (10% acitve) 15% JP (3% active) US pending 98
Tinosorb® S Aqua Benefits
Based on highly efficient Tinosorb® S technology
Increased formulation flexibility - Addition before or after emulsification, short term exposure to higher temperatures possible - Prevention of overload of the oil phase = more flexibility to adapt the oil phase
Improved efficacy due to more homogeneous filter distribution - Water resistance of formulations is not negatively impacted and could even be improved
99
Tinosorb® S Aqua Formulation Flexibility Plus Point Lotion SPF50+ (GEUV09102-4-18)
Uvinul® T150 PBSA T-Lite® SF-S Uvinul® A Plus Tinosorb® S
Filter composition
3.5% 4.0% 4.5% 9.0% 3.5%
Filter concentration
24.5%
Water Resistant Sun Matrix SPF50+ (GEUV10080-4-1) 3.0% 3.0% 8.0% 2.0% 10%
Uvinul® T150 PBSA Uvinul® A Plus Tinosorb® S Tinosorb® S Aqua
18.0% Replacement of TiO2 = transparency
Filter Cost
100%
~85%
Emollient Concentration needed
30%
20%
Performance
SPF (in vivo) UVA-PF
53 / 73 22.2
SPF (in vivo) 59.6 / 68.4 UVA-PF (in vitro) 23.7 WR (2*20min) 63.9%
Increased formulation flexibility, reduced filter concentration, lower oil phase, enhanced transparency, reduced filter cost
106
Tinosorb® S Aqua Manufacturing Process in O/W Tinosorb® S Aqua
Before emulsification
75°C
Macroscopic evaluation
Homogeneous
Tinosorb® S Aqua
Tinosorb® S Aqua
Emulsion
Emulsion
75°C
Homogeneous
30°C
Homogeneous
Microscopic evaluation X125 under cross polarized light – After 3 months
Independent from manufacturing process homogeneous distribution of Tinosorb® S Aqua is achieved.
Uvinul® A Plus Profile INCI-Name:
Diethylamino Hydroxybenzoyl Hexyl Benzoate (DHHB)
US FDA Drug Name (USP):
--
Appearance:
CAS Number:
White to light salmon granular UV Spectrum 302776-68-7
Melting point:
54°C
Type:
Oil and alcohol soluble
Molecular mass:
397.5 g/mol
Approved use conc.:
10% EU, Asia, JP
Uvinul® A Plus
113 113
Uvinul® A Plus Benefits Uvinul® A Plus, the only photostable UVA filter on the market
Absolute photostable UVA protection
High formulation flexibility due to excellent solubility Good compatibility with other UV filters and cosmetic ingredients Excellent performance in radical protection
114
Uvinul® A Plus and BMDBM Uvinul® A Plus can easily replace BMDBM in formulations Comparable absorption curve Better solubility
1200
Perfect photostability
1000
DHHB
BMDBM
BMDBM after 12MED irradiation
E (1,1)
800
600
400
200
390
370
350
330
310
290
0
Wavelength (nm) 07.03.2012
116
Uvinul® A Plus Contribution to SPF and UVA-PF
Base: 10% EHMC
addition of Uvinul A Plus
Uvinul® A Plus Solubility in various cosmetic oils compared to BMDBM 45
Solubility of in Selected Cosmetic Oils (%) at 25°C
40
Uvinul® A Plus
35
Solubility %
30
BMDBM
25 20 15 10 5 0
Cosmetic Oils
Uvinul® A Plus has superior solubility in selected cosmetic oils than BMDBM 07.03.2012
124
Uvinul® A Plus Influence of emulsifier on emulsion color Summary
L*: 92.0 a*: -7.3 b*: 17.5
L*: 93.1 a*: -5,8 b*: 15.0
5.0% Eumulgade® PL 68/50 1.0% Eumulgin® Prisma
3.5% Cremophor® A6 1.5% Cremophor® A25
5/10/2013
1.5% Eumulgin® Prisma
L*: 89.3 a*: -10.0 b*: 26.8
L*: 93.6 a*: -7.0 b*: 17,2 magnification x 400
L*: 94.4 a*: -7.0 b*: 16.1
3.5% Eumulgin® BA 25 1.5% Lameform® TGI
2.0% Tinovis ADE Technical Service SunCare E-EMC/DU
Spectrometer Lambda 650; CIELab; D65 / 10 o 131
Uvinul® A Plus Formulation Tips It is possible to use Uvinul® A Plus in a wide spectrum of polar oils due to its excellent solubility in a wide range of emollients
Good solubility also in Ethanol
Check cristallization at low temperatures
153
BASF Portfolio Zinc Oxide
Trade Name
INCI
Product description
Z-COTE®
Zinc Oxide
Water and Oil dispersible (amphiphilic character)
Z-COTE® HP1
Zinc Oxide (and) Triethoxycaprylylsilane
Oil / Silicone phase dispersible
154
BASF Personal Care
Z-COTE® HP1 Description Chemical name
Hydrophobic Zinc Oxide
INCI-name
Zinc Oxide (and) Triethoxycaprylylsilane
CAS-numbers
1314-13-2, 63148-62-9
Structural formula
ZnO
Molar mass
81.37 g/mol (for ZnO)
Appearance
white powder
Odor
none
Purity
99%
Particles size
mean is 140nm (laser scattering particles size distribution analyser)
20% < 100nm
155
BASF Personal Care
Z-COTE® HP1 Approval Situation
EU:
Positive SCCS opinion on ZnO (nano form) SCCS (Scientific Committee on Consumer Safety), Opinion on ZnO (nano form), 18 September 2012
USA:
ZnO is approved in the Cat.I of the FDA Final Monograph for Sunscreen Drug product for
OTC Human Use. Upper limit = 25% Not allowed in combination with BMDBM
Japan
Not considered as UV absorbers Use without limitation (except eyeliner, lip, oral & bath preparation) 156
BASF Personal Care
Z-COTE® HP1 Formulation Tips
Choose appropriate dispersant aids: Uvinul® MC80 / Uvinul ® N539T Cetiol ® B / Cetiol ® AB
Disperse the ZnO under homogenizer (high energy needed)
Disperse each powder separatly
157
BASF Personal Care
Add 0.05% PBSA to avoid pH shift
If pH adjustement is necessary use Citric Acid only when emulsion is finish
Anionic surfactant (low levels 0.2% Lanette® E) helps to stabilise emulsion
Z-COTE® HP1 Formulation Tips
Disperse ZnO in appropriate hot
Homogenizer ZnO
75°C - 80°C
158
BASF Personal Care
(75-80°C) oil phase under high speed homogenizer
Add rest of hot oil phase Prepare formulation Adjust pH with Citric Acid
Uvinul® T 150 Profile INCI-Name:
Ethylhexyl Triazone (EHT)
US FDA Drug Name (USP):
Ethylhexyl Triazone
UV Spectrum
Appearance:
White powder
CAS Number:
88122-99-0
Melting point:
128-132°C
Type:
Oil Soluble
Molecular mass:
823 g/mol
Approved use conc.:
5% EU, JP, Asia US pending
Uvinul T150
159
Uvinul® T 150 Benefits Uvinul® T 150, the most powerful and photo stable UVB filter Highest efficient UVB filter in the market Excellent compatibility with all UV filters Excellent photo stability Odor free (PC12/118) and colorless Combine with broad-spectrum filters and/or UVA filters in order to achieve better performance also in respect of SPF
160
Uvinul® T 150 Solubility in Selected Cosmetic Oils Uvinul® T 150 Solubility in Selected Cosmetic Oils (%) 25°C
*Beware of patent restrictions
18
16 14
Solubility %
12 10
8 6
4 2 0
*
*
*
Cosmetic Oils
164
Uvinul® T 150 Formulation Tips
Choose emollients with best solubility for Uvinul® T 150 like Ethylhexyl Methoxycinnamate (Uvinul® MC 80), Dibutyl Adipate (Cetiol® B)
Dissolve Uvinul® T 150 completely in the oil phase (at elevated temperature)
Check potential crystallization (microscopy) at low storage temperatures
The formulation itself (emulsifiers, stabilizers and thickeners) has a positive impact (less re-crystallization of Uvinul ® T 150)
169
Uvinul® MC 80 Profile INCI-Name:
Ethylhexyl Methoxycinnamate (EHMC)
US FDA Drug Name (USP):
Octinoxate
Appearance:
Colourless liquid UV Spectrum
CAS Number:
5466 – 77 - 3
Type:
Oil soluble
Molecular mass:
290 g/mol
Approved use conc.:
10.0% EU, JP 7.5% KR, US 20.0% JP
Uvinul MC 80
170
Uvinul® MC 80 Formulation Tips Avoid combination with BMDBM due to photo degradation O
O
O O
EHMC O
h·
+
O O
O
OH OH
O
O
Increased photoinstability because of 2+2-heterophotocycloaddition of BMDBM and EHMC
BMDBM
Stabilize Uvinul® MC 80 by the use of stabilizers like Tinosorb® S Use Uvinul® MC 80 as excellent solubilizer for oil soluble UV filters
172
Uvinul® MC 80 Impact of photostability in formulations Filter composition (%) 10% Uvinul® MC80 (EHMC) 5% BMDBM
7% Uvinul® MC80 (EHMC) 3% Uvinul® A Plus (DHHB) 1% Tinosorb® S (BEMT)
7% Uvinul® MC80 (EHMC) 4% Tinosorb® M (MBBT)
Lack of photostability result in changed performance during use and high filter concentration needed 07.03.2012
173
Uvinul® N 539 T Profile INCI-Name:
Octocrylene
US FDA Drug Name (USP):
Octocrylene
Appearance:
Clear yellow viscous liquid
CAS Number:
6197 – 30 - 4
Type:
Oil soluble
Molecular mass:
361 g/mol
Approved use conc.:
10% EU, US, JP, Asia
UV Spectrum Uvinul 539 T
174
Uvinul® N 539 T Benefit Uvinul® N 539 T – wide UVB absorbance band and efficient photo stabilization
High photo stability
Efficient stabilizer for photo instable filters
Contribution to UVAII absorbance of the final product
175
Uvinul® N 539 T Formulation Tips Easy to use Due to the low spreading behaviour high spreading emollients are recommended for a better sensory
176
Best Emollients for Sun Care Overview Remarks
Hair
Color
Body
Face
Applications
Deodorant
Wax
High
Medium
Refractive Viscosity index ** mPas at 20 oC at 20 oC
Antiperspirant
Spreading Polarity Value mm2/10 min
Spreading
Sun
INCI Name
Slow
Tradename
Propylheptyl Caprylate
·
1900
medium
1.444
5
· ·* · · · · ·
The Happy Emollient Multidimensional Softness
Dicaprylyl Carbonate
·
1600
medium
1.436
7
·
· · · · ·
The Benchmark for dry emollients
Cetiol® RLF
Caprylyl–Caprylate/Caprate
·
1400
medium
1.436
5
·
· · · · ·
The emollient for sensitive skin
Cetiol® C 5
Coco-Caprylate
·
1300
medium
1.437
5
· ·* · · · · ·
High spreading emollient The silicon alternative
Cetiol® B
Dibutyl Adipate
·
1000
high
1.435
6
·
· · ·
·
Very good solubility properties for crystalline UV filter
· · ·
·
Commonly used emollient in Sun care
Cetiol® Sensoft
Cetiol® CC
Cetiol® AB
Myritol® 331
C12-15 Alkylbenzoate
·
700
high
1.485
30
·
Cocoglycerides
·
750
high
1.455
45
·
* Anhydrous formulations only 177
BASF Personal Care
· · ·
Medium spreading emollient with good solubility properties for crystalline UV filter
Best Emulsifiers for Sun Care Overview Sprayable Emulsion
++
+
++
+
++
++
++
Flexible emulsifier for different applications and ingredients
Eumulgin® SG
++
++
+
++
+
++
++
++
Strong emulsifier especially for high amount of electrolytes
Eumulgin® VL 75
++
+
++
++
+
++
++
Liquid emulsifier for sprayable applications
Emulgade® PL 68/50
++
++
++
++
+
Mild emulsifier with good sensoric
++
++
++
Flexible W/O emulsifier
++
++
+
W/O emulsifier for liquid emulsions
++
Dehymuls® LE
++
++
184
BASF Personal Care
++
Remarks
Sun Care
W/O ++
+
Body Care
Fluid Emulsion
++
Dehymuls® PGPH
Application Face Care
Gel Cream
Texture Creamy Emulsion
Eumulgin® Prisma
P.I.T.
Technology O/W
Emulsifier
Skin Care Leave-On Polymers Guide Contains EO/PO
Ethanol Compatibility
Salt Tolerance
Sensory Profile
Thickening
Emulsion Stabilization
Body Care
Face Care
Sun Care
>88
P
Anionic
0.2 – 1
6 – 12
No
++
+
++
++
++
Cosmedia® Triple C
Polyquaternium-37 (and) Dicaprylyl Carbonate (and) Lauryl Glucoside
~50
L
Cationic
0.5 – 3
3 – 11
No
+++
+
+++
+
++
Cosmedia® Ultragel 300
Polyquaternium-37
> 92
P
Cationic
0.5 – 1.5
3 – 11
No
+++
+
+++
++
+
Luvigel® EM
Caprylic/Capric Triglycerides (and) Sodium Acrylates Copolymer
~25
L
Anionic
0.5 – 3
6–9
Yes
+
o
+
++
++
Luvigel® STAR AT
Polyurethane-39
~20
L
Non-Ionic
0.5 – 5
2 – 12
Yes
++
+++
++
+
o
Tinovis®
Sodium Acrylates Copolymer (and) Hydrogenated Polydecene (and) PPG-1 Trideceth-6
~55
L
Anionic
0.5 – 1.5
5 – 12
Yes
++
+
+
++
++
Carbomer
>97
P
Anionic
0.1 – 1.0
4 – 12
No
+++
++
o
+++
++
>97
P
Anionic
0.1 – 1.0
3 – 10
No
++
+++
+
+
++
ADE
Rheocare® C Plus Rheocare® XG
Physical form:
191
Xanthan Gum
P = Powder L = Liquid
Performance:
o Low
+ Good ++ Very Good
AP/Deo
pH application range
Sodium Polyacrylate
INCI Name
Self Tanning
Recommended dosage as is in %
Cosmedia® SP
Trade Name
Clear Gels
Type
Application
Physical form
Performance
Active Polymer %
Product Information
Remarks
Improve cushion
High transparency
Associative thickener, Tolerant to H2O2
High transparency, improves peaking
+++ Excellent
Importance of Efficient UVA Protection
Factors Influencing Skin Aging Intrinsic (genetic, life-age related) factors - they can‘t be influenced
Extrinsic (environmental) factors can contribute to a much higher extent to the visible signs of aging than intrinsic factors – but they can be influenced !
UV LIGHT
NUTRITION
LIFESTYLE POLLUTION
208
UV light damages Erythema
Contribution to skin cancer
Skin aging
Skin pigmentation
Imunosuppression
20
Action spectrum of ROS formation in human 1,0
Arb. Units
0,8 0,6 0,4 0,2 0,0
290
315
340
365
WL (nm)
Gary Haliday, ESP Conference 2011 (ESP = European Society of Photobiology)
390
Correlation of UVA-PFsim and RSFexp
UVA-PF (sim)
20
n = 17
15
r = 0.932
10
slope = 0.51 5
0 0
10
20
30
40
RSF (exp)
Correlation of UVA-PF and RSF Confirmed 211
UVA Protection for Daily Sun Care Options
UVA protection
Minimal UVA Protection
Optimal UVA Protection «Spectral Homeostasis»
Same requirements for UVA protection as in SunCare EC recommendation for UVA protection (Sept. 2006) Attenuation in intensity but without altering the quality of the natural spectrum of sunlight reaching the skin
Criterion
UVA-PF / SPF ≥ 1/3
Very well balanced absorbance homoeostasis 1,2
0,9 Extinction
Options
0,6
0,3
Before Irradiation (adjusted) After Irradiation (adjusted)
0,0 290
310
330
350
370
390
/ nm
Radical Protection (anti-ageing claims)
212
Small amounts of photostable UVA filters reduce free radical formation and long term UVA damage significantly
For Day Care without SPF claim
An in vivo study on Asian volunteers Testpanel:
22 Volunteers of Asian origin
(14 females and 8 males, between 28 and 42 years old, mother and father originating either from Thailand or the Philippines).
Irradiation regime:
3x / week, 12 weeks with <1 MED
On volunteers back; Irradiation by Solar Light Simulator (SSR) for 12 weeks, i.e. 3x / week, 12 weeks with <1MED (dose monthly adjusted; effective dose UV-A 320 - 400 nm 24 -26 J/cm2, UV-B 280 - 320 0,04 - 0,06 J/cm2) 30 min after cream application.
Control:
unprotected, irradiated skin area
Test Products We tested 3 day creams with increasing amounts of Tinosorb®M, i.e. of UV-A protection 2% EHMC 1% Tinosorb M (SPFcalc 5.3)
2% EHMC 2% Tinosorb M (SPFcalc 6)
2% EHMC 4% Tinosorb M (SPFcalc 7)
Tinosorb M is an organic particulate broad-spectrum filter and such ideal for combination with cosmetic actives used in day care cosmetics.
Further ingredients: Aqua (up to 100%) ; Caprylic/Capric Triglyceride (5%) ; C12-15Alkyl Benzoate (5%), Cetearyl Isononanoate (5%); Glyceryl Stearate (3%); Glycerin (3%); Potassium Cetyl Phosphate (2%); Cetyl Alcohol (1%); Cetyl Stearate (1%); Phenoxyethanol/ Parabenes (1%); Steareth-10 Allyl Ether/Acrylates Copolymer (0.5%). Ethylhexyl Methoxycinnamate (2%) ; Tinosorb®M (1 – 4%)
UV Transmission of the test products 2% EHMC 1% Tinosorb®M (SPFcalc 5.3)
2% EHMC 2% Tinosorb®M (SPFcalc 6)
2% EHMC 4% Tinosorb®M (SPFcalc 7)
100%
100%
100%
0%
0%
0%
60% of UVA I is absorbed
70% of UVA I is absorbed
80% of UVA I is absorbed
High absorption of UVA light is achieved with low concentrations of Tinosorb M
Test Results Start
1st month 2nd month 3rd month 100%
2% EHMC/ 1% Tinosorb® M SPFcalc. 5.3
60% UV-AI is absorbed
2% EHMC/ 2% TIinosorb® M SPFcalc. 6 2% EHMC/ 4% Tinosorb® M SPFcalc. 7
UV Transmission
0% 100%
70% UV-AI is absorbed 0% 100%
80% UV-AI is absorbed 0%
100%
irradiated (<1 MED) No protection 290
320 340
0% 400 nm
The better UV-A protection, the more effective the cream
Conclusion 90% of UV induced free radicals are generated by UVA light Free radicals in viable skin are a main factor of accelerated skin aging UVA light is a main trigger for melanin synthesis and skin tanning
Efficient UVA protection provides an “anti aging” effect and is most efficient in tanning prevention which is the first step for efficient skin lightening.
5/10/2013
217
DISCLAIMER This document, or any answers or information provided herein by BASF, does not constitute a legally binding obligation of BASF. While the descriptions, designs, data and information contained herein are presented in good faith and believed to be accurate, they are provided for your guidance only. Because many factors may affect processing or application/use, we recommend that you make tests to determine the suitability of a product for your particular purpose prior to use. It does not relieve our customers of the obligation to perform a full inspection of the products upon delivery or any other obligation. The claims and supporting data provided in this publication have not been evaluated for compliance with any jurisdiction’s regulatory requirements and the results reported may not be generally true under other conditions or in other matrices. Users must evaluate what claims and information are appropriate and comply with a jurisdiction’s regulatory requirements. NO WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, ARE MADE REGARDING PRODUCTS DESCRIBED OR DESIGNS, DATA OR INFORMATION SET FORTH, OR THAT THE PRODUCTS, DESIGNS, DATA, OR INFORMATION MAY BE USED WITHOUT INFRINGING THE INTELLECTUAL PROPERTY RIGHTS OF OTHERS. IN NO CASE SHALL THE DESCRIPTIONS, INFORMATION, DATA, OR DESIGNS PROVIDED BE CONSIDERED A PART OF OUR TERM SAND CONDITIONS OF SALE.
218
BASF Personal Care
219
BASF Personal Care